Mechanisms of disease for the clinician: Systemic lupus erythematosus

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 4, 2013, Pages 228-232

  Frieri, Marianne ^a  

^a NASSAU UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BELIMUMAB; CORTICOSTEROID; CYCLIC AMP RESPONSIVE ELEMENT MODULATOR; CYCLOPHOSPHAMIDE; GAMMA INTERFERON; HYDROXYCHLOROQUINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 4; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE; PROTEIN C FOS; RITUXIMAB; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR;

ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTING CELL; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS; ATHEROSCLEROSIS; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CELL ACTIVATION; CELL ACTIVITY; CELL FUNCTION; CELL LOSS; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPSTEIN BARR VIRUS INFECTION; ETHNIC DIFFERENCE; FALSE POSITIVE RESULT; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HEREDITY; HUMAN; IMMUNE DYSREGULATION; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL PARAMETERS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; INFECTION; INTRACELLULAR SIGNALING; LABORATORY DIAGNOSIS; LATENT VIRUS INFECTION; LIFESTYLE; LOW DRUG DOSE; LUPUS ERYTHEMATOSUS NEPHRITIS; LUPUS LIKE SYNDROME; MEDIATOR; MIXED CONNECTIVE TISSUE DISEASE; MOLECULAR MECHANICS; MOLECULARLY TARGETED THERAPY; NEUROTOXICITY; PERICARDITIS; PHYSICIAN; PLEURISY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; RASH; RETINA DISEASE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SKIN ATROPHY; SKIN DISEASE; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; TREATMENT RESPONSE; VIRUS GENE; VIRUS LOAD; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84875461762     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2012.12.010     Document Type: Review

References (35)

1. S. Manzi Epidemiology of systemic lupus erythematosus Am J Manag Care 7 16 suppl 2001 s474 s479
2. M. Petri Epidemiology of systemic lupus erythematosus Best Pract Res Clin Rheumatol 16 2002 8447 8858
3. E.F. Chakravarty, T.M. Bush, and S. Manzi Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates using hospitalization data Arthritis Rheum 56 2007 2092 2094 (Pubitemid 47110409)
4. C. Franco, W. Yoo, and D. Franco Predictors of end stage renal disease in African Americans with lupus nephritis Bull NYU Hosp Jt Dis 68 2010 251 256
5. C. Flower, A.J. Hennis, and I.R. Hambleton Systemic lupus erythematosus in an African Caribbean population: incidence, clinical manifestations, and survival in the Barbados National Lupus Registry Arthritis Care Res (Hoboken) 64 2012 1151 1158
6. Y. Shapira, N. Agmon-Levin, and Y. Shoenfeld Geoepidemiology of autoimmune rheumatic diseases Nat Rev Rheumatol 6 2010 468 476
7. E. Alonso-Perez, M. Suarez-Gestal, and M. Calaza Association of systemic lupus erythematosus clinical features with European population genetic substructure PLoS One 6 2011 e29033
8. S.G. Guerra, and T.J. Vyse Cunninghame Graham DS. The genetics of lupus: a functional perspective Arthritis Res Ther 14 2012 211
9. C.M. Hedrich, and G.C. Tsokos Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases Trends Mol Med 17 2011 714 724
10. C.C. Mok, and C.S. Lau Pathogenesis of systemic lupus erythematosus J Clin Pathol 56 2003 481 490 (Pubitemid 36819418)
11. L.S. Davis, J. Hutcheson, and C. Mohan The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus J Interferon Cytokine Res 31 2011 781 789
12. H17 cells and their expanding role in systemic lupus erythematosus Arthritis 2011 2011 810649
13. V.R. Moulton, D.R. Holcomb, and M.C. Zajdel Estrogen upregulates cyclic AMP response element modulator α expression and downregulates interleukin-2 production by human T lymphocytes Mol Med 18 2012 370 378
14. A.H. Draborg, K. Duus, and G. Houen Epstein-Barr virus and systemic lupus erythematosus Clin Dev Immunol 2012 2012 370516
15. A. Alunno, E. Bartoloni, and O. Bistoni Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new Clin Dev Immunol 2012 2012 823085
16. P. López, J. Gómez, and C. Prado Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment J Rheumatol 35 2008 1559 1566
17. Y. Liu, Y. Yu, and G. Matarese Cutting edge: fasting-induced hypoleptinemia expands functional regulatory T cells in systemic lupus erythematosus J Immunol 188 2012 2070 2073
18. B. Terrier, N. Costedoat-Chalumeau, and M. Garrido Interleukin 21 correlates with T Cell and B cell subset alterations in systemic lupus erythematosus J Rheumatol 39 2012 1819 1828
19. M.A. Lozovoy, A.N. Simão, and C. Panis Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus Lupus 20 2011 1250 1259
20. M. Frieri Complement related diseases Allergy Asthma Proc 23 2002 319 324
21. K.B. Elkon, and A. Wiedeman Type I IFN system in the development and manifestations of SLE Curr Opin Rheumatol 24 2012 499 505
22. A.C. Shirali, and D.R. Goldstein Tracking the toll of kidney disease J Am Soc Nephrol 19 2008 1444 1450
23. M. Frieri, M. Samih, and H. Liu Toll-like receptor 9 and vascular endothelial growth factor levels in human kidneys from lupus nephritis patients J Nephrol 25 2012 1041 1046
24. A. Joseph, R. Brasington, and L. Kahl Immunologic rheumatic disorders J Allergy Clin Immunol 125 2 suppl 2 2010 S204 S215
25. C. Yildirim-Toruner, and B. Diamond Current and novel therapeutics in the treatment of systemic lupus erythematosus J Allergy Clin Immunol 127 2011 303 312
26. E. Boren, G. Cheema, and S. Naguwa The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases J Autoimmun 30 2008 90 98
27. Tang C, Godfrey T, Stawell R, et al. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. J Intern Med. Published online ahead of print July 25, 2012. doi: 10.1111/j.1445-5994.2012. 02886.x.
28. A. Coca, and I. Sanz Updates on B-cell immunotherapies for systemic lupus erythematosus and Sjögren's syndrome Curr Opin Rheumatol 24 2012 451 456
29. M. Frieri Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches Curr Allergy Asthma Rep 12 2012 25 32
30. M. Frieri, and A. Valluri Vitamin D deficiency: a risk factor for allergic and immune mechanisms Allergy Asthma Proc 32 2011 438 444
31. M. Frieri Identification of masqueraders of autoimmune disease in the office Allergy Asthma Proc 24 2003 421 429 (Pubitemid 38142607)
32. A. Mansur, and M. Frieri Behçet's disease versus Behçet's syndrome with some criteria for systemic lupus erythematosus Pediatr Asthma Allergy Immunol 12 1998 53 59 (Pubitemid 28334072)
33. J. Kaplan, P. Anand, and M. Frieri Rash, drug hypersensitivity and autoimmunity in a 20 year old Ann Allergy Asthma Immunol 95 2005 111 114
34. M. Frieri, and A. Argyriou Is there a relationship between fibromyagia and rhinitis? Allergy Asthma Proc 33 2012 1 7
35. M. Cojocaru, I.M. Cojocaru, and I. Silosi Manifestations of systemic lupus erythematosus Maedica (Buchar) 6 2011 330 336